Zulfa Omer
Clinical trials sponsored by Zulfa Omer, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to wipe out hidden leukemia cells Results expected Jul 2027 (estimated)
-
Could taking drug holidays improve CLL treatment?
Disease control Recruiting nowThis study tests whether taking the targeted drug venetoclax on an intermittent schedule (with breaks) works as well as taking it continuously, when combined with acalabrutinib, in people with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. About …
Phase 2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy aims to wipe out hidden leukemia cells
Disease control Recruiting nowThis study tests whether adding the drug epcoritamab after standard treatment can make chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) disappear more completely. About 22 adults who have already received at least 12 months of a BTK inhibitor (acalabrutinib …
Phase 2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC